These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 2578703
1. Antinuclear antibodies appearing during PUVA therapy. Bruze M, Ljunggren B. Acta Derm Venereol; 1985; 65(1):31-6. PubMed ID: 2578703 [Abstract] [Full Text] [Related]
2. Fatal connective tissue disease with antinuclear antibodies following PUVA therapy. Bruze M, Krook G, Ljunggren B. Acta Derm Venereol; 1984; 64(2):157-60. PubMed ID: 6203306 [Abstract] [Full Text] [Related]
7. Comparison of phototherapy (UV-B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis. Boer J, Hermans J, Schothorst AA, Suurmond D. Arch Dermatol; 1984 Jan; 120(1):52-7. PubMed ID: 6691715 [Abstract] [Full Text] [Related]
8. Histologic, immunofluorescent, and antinuclear antibody findings in PUVA-treated patients. Levin DL, Roenigk HH, Caro WA, Lyons M. J Am Acad Dermatol; 1982 Mar; 6(3):328-33. PubMed ID: 7040505 [Abstract] [Full Text] [Related]
9. Antinuclear antibodies during psoralens plus ultraviolet A (PUVA) therapy--are they worthwhile? Picascia DD, Rothe M, Goldberg NS, Roenigk HH. J Am Acad Dermatol; 1987 Mar; 16(3 Pt 1):574-7. PubMed ID: 3493272 [Abstract] [Full Text] [Related]
10. Skin carcinomas and treatment with photochemotherapy (PUVA). Lindskov R. Acta Derm Venereol; 1983 Mar; 63(3):223-6. PubMed ID: 6192635 [Abstract] [Full Text] [Related]
11. Risk of skin tumors in psoralen- and ultraviolet A-treated patients. Henseler T, Christophers E. Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033 [Abstract] [Full Text] [Related]
12. The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-up. Al-Allaf AW, Ottewell L, Pullar T. Clin Rheumatol; 2002 Nov; 21(6):472-7. PubMed ID: 12447630 [Abstract] [Full Text] [Related]
13. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients. Berne B, Fischer T, Michaëlsson G, Norén P. Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278 [Abstract] [Full Text] [Related]
14. [Combined oral retinoid and PUVA therapy in the treatment of psoriasis and psoriatic arthropathy (author's transl)]. Thivolet J, Robart S, Vignon E. Ann Dermatol Venereol; 1981 Feb; 108(2):131-7. PubMed ID: 6972721 [Abstract] [Full Text] [Related]
15. [Alpha 1-fetoprotein--a marker of potential PUVA side-effects in psoriasis?]. Wollina U, Schulze M, Schaarschmidt H, Barta U, Pfeiffer L, Knopf B, Horn A. Z Hautkr; 1985 Mar 15; 60(6):527-30. PubMed ID: 2581382 [Abstract] [Full Text] [Related]
16. [Antinuclear antibodies and PUVA therapy]. Cattaneo R, Pancera C, Fenini MG, Gavazzoni R, De Costanza F. G Ital Dermatol Venereol; 1982 Mar 15; 117(4):207-10. PubMed ID: 6985322 [No Abstract] [Full Text] [Related]
17. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA. Kallenberg CG, de Jong MC, Walstra TM, Kardaun S, The TH. J Rheumatol; 1983 Oct 15; 10(5):733-40. PubMed ID: 6606041 [Abstract] [Full Text] [Related]
18. Itch following photochemotherapy for psoriasis. Rogers S, Marks J, Shuster S. Acta Derm Venereol; 1981 Oct 15; 61(2):178-80. PubMed ID: 6165204 [Abstract] [Full Text] [Related]
19. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?]. Harnes DK, Thune P. Tidsskr Nor Laegeforen; 1993 Jan 20; 113(2):200-1. PubMed ID: 8430401 [Abstract] [Full Text] [Related]
20. Antinuclear antibodies in children with localized scleroderma. Rosenberg AM, Uziel Y, Krafchik BR, Hauta SA, Prokopchuk PA, Silverman ED, Laxer RM. J Rheumatol; 1995 Dec 20; 22(12):2337-43. PubMed ID: 8835572 [Abstract] [Full Text] [Related] Page: [Next] [New Search]